Adagio Medical Holdings (ADGM) Gains from Investment Securities (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Gains from Investment Securities of $131000.0 for Q1 2026, up 444.74% on a YoY basis from $24048.3 in Q1 2025, and up 137.01% sequentially from -$354000.0 in Q4 2025.
Adagio Medical Holdings (ADGM) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Gains from Investment Securities data on file, last reported at $131000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 444.74% year-over-year to $131000.0; the trailing twelve-month figure through Mar 2026 stood at $149000.0 (up 102.97% YoY), and the FY2025 full-year result was -$20000.0, up 99.7% from the prior year.
- Gains from Investment Securities advanced to $131000.0 in Q1 2026, from -$354000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $231000.0 in Q3 2025 to a low of -$5.0 million in Q3 2024.
- A 4-year average of -$489400.0 and a median of -$7500.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities sank 21721.74% in 2024 and surged 444.74% in 2026, its largest moves.
- Tracing ADGM's Gains from Investment Securities over 4 years: stood at -$41000.0 in 2023, then tumbled by 12029.27% to -$5.0 million in 2024, then soared by 92.88% to -$354000.0 in 2025, then surged by 137.01% to $131000.0 in 2026.
- Business Quant data shows ADGM's Gains from Investment Securities at $131000.0 in Q1 2026, -$354000.0 in Q4 2025, and $231000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Adagio Medical Holdings | 21.36 Mn | 21.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131,000.00 |
| Mar 31, 2026 | 131,000.00 |
| Dec 31, 2025 | -354,000.00 |
| Dec 31, 2025 | -354,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -94,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |